Sclerosis News and Research

RSS

Benefits and underutilization of ITB therapy for multiple sclerosis

A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.

4 Feb 2011

USF Health sponsors conference on Parkinson's disease and multiple sclerosis

Some of the country's leading physicians and researchers in the fields of Parkinson's disease and multiple sclerosis will gather later this month to discuss the latest advances in the diagnosis and treatment of these neurological disorders.

3 Feb 2011

Older people with metabolic syndrome may face high risk of developing memory loss

Older people with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at a higher risk for memory loss, according to a study published in the February 2, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 Feb 2011

First blood-based diagnostic test for LAM

Circadian Technologies has announced today that in conjunction with Cincinnati Children's Hospital Medical Center it has begun offering its LAM diagnostic, which is offered as a laboratory test compliant with CAP (College of American Pathologists) /CLIA regulations.

2 Feb 2011

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

Histamine can be an important molecule to develop new treatments for MS

If you think histamines are your nemesis during allergy season, here's something that might change your perspective. New research published in the Journal of Leukocyte Biology shows that histamine could be an important molecule to developing new treatments for multiple sclerosis.

1 Feb 2011

HPN President announces gift to UCLA to advance research for Neural Regeneration

Dr. Richard Merkin, President and CEO of Heritage Provider Network, and the Merkin Family Foundation announce the generous gift to the UCLA Department of Neurology at the David Geffen School of Medicine at UCLA to advance research for Neural Regeneration.

29 Jan 2011

Arena reduces workforce by 25% and provides update on lorcaserin

Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.

28 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

Receptos begins RPC1063 Phase 1 clinical study in patients with multiple sclerosis

Receptos, announced today that their highly selective sphingosine-1-phosphate receptor 1 agonist, RPC1063, has been administered to the first subject in a single-ascending and multiple-ascending dose design Phase 1 clinical safety study.

28 Jan 2011

Research finds link between increased hygiene and higher rates of certain diseases in women

Little girls growing up in western society are expected to be neat and tidy - "all ribbon and curls" - and one researcher who studies science and gender differences thinks that emphasis may contribute to higher rates of certain diseases in adult women.

27 Jan 2011

Molecular mechanism in nerve fibers ensures rapid conductance of nervous system impulses

New research from the University of North Carolina at Chapel Hill School of Medicine describes a key molecular mechanism in nerve fibers that ensures the rapid conductance of nervous system impulses.

27 Jan 2011

Pill for multiple sclerosis in the pipeline

Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.

25 Jan 2011

EMA CHMP issues negative opinion against Biogen Idec's FAMPYRA for multiple sclerosis

Biogen Idec announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a negative opinion recommending against approval of FAMPYRA to improve walking ability in adult patients with multiple sclerosis (MS) in the European Union. Biogen Idec intends to appeal this opinion and request a re-examination of the decision by the CHMP.

21 Jan 2011

Researchers map complex choreography used by immune system's T cells to recognize pathogens

Researchers have for the first time mapped the complex choreography used by the immune system's T cells to recognize pathogens while avoiding attacks on the body's own cells.

21 Jan 2011

NGOs, IAOMT urge to ban mercury-containing products, including dental amalgam

Mercury, the main ingredient in "silver" or amalgam fillings, will be the subject of a United Nations conference to be held in Chiba, Japan on January 24-28. Members of various non-governmental organizations, as well as dentists and scientists from groups such as the International Academy of Oral Medicine and Toxicology, will be attending and urging a ban on products containing mercury, including dental amalgam.

21 Jan 2011

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Health care systems around the world are failing to use evidence obtained through research when making decisions, causing inefficiencies and reduced quantity and quality of life, according to a leading expert in the field of "knowledge translation."

20 Jan 2011

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

A new guideline from the American Academy of Neurology recommends using plasma exchange to treat people with severe relapses in multiple sclerosis and related diseases, as well as those with certain kinds of nerve disorders known as neuropathies.

18 Jan 2011

'Master switch' protein in white blood cells linked to inflammation

Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.

18 Jan 2011

Sclerosis News and Research

Benefits and underutilization of ITB therapy for multiple sclerosis

USF Health sponsors conference on Parkinson's disease and multiple sclerosis

Older people with metabolic syndrome may face high risk of developing memory loss

First blood-based diagnostic test for LAM

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

Histamine can be an important molecule to develop new treatments for MS

HPN President announces gift to UCLA to advance research for Neural Regeneration

Arena reduces workforce by 25% and provides update on lorcaserin

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

Receptos begins RPC1063 Phase 1 clinical study in patients with multiple sclerosis

Research finds link between increased hygiene and higher rates of certain diseases in women

Molecular mechanism in nerve fibers ensures rapid conductance of nervous system impulses

Pill for multiple sclerosis in the pipeline

EMA CHMP issues negative opinion against Biogen Idec's FAMPYRA for multiple sclerosis

Researchers map complex choreography used by immune system's T cells to recognize pathogens

NGOs, IAOMT urge to ban mercury-containing products, including dental amalgam

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

'Master switch' protein in white blood cells linked to inflammation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News